Rena Fox, MD

Title(s)Professor, Medicine
SchoolSchool of Medicine
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford UniversityB.A.1991Human Biology
    Bryn Mawr CollegePost-Baccalaureate1992
    University of California San DiegoM.D.1997School of Medicine
    University of WashingtonInternship and Residency2000Internal Medicine
    UCSFClinician-Educator Fellowship2001General Internal Medicine

    Collapse Overview 
    Collapse Overview
    Dr. Rena Fox is a Professor of Medicine at University of California, San Francisco (UCSF). She has been on the faculty in the Division of General Internal Medicine for 18 years. Dr. Fox was an undergraduate at Stanford, got her MD at UC San Diego and did her internal medicine residency at University of Washington. She was a general medicine fellow at UCSF with an interest in hepatitis C during which time she was trained by UCSF hepatologists in viral hepatitis and since then, Dr. Fox has been the sole faculty member at UCSF who is both an expert in hepatitis C and is a general internist, and is one of the few people in the country in this unique position. Dr. Fox is internationally recognized as an educator – she lectures around the country and she has been working with the Veterans Administration for a decade on hepatitis C educational tools, national policies and as the Medical Editor of the VA Viral Hepatitis Website. As part of the DHHS Hepatitis Action Plan, and the CDC aim to educate the country’s physicians in hepatitis C, she is on a national advisory board with the University of Washington, creating an online hepatitis C curriculum for HCV education. She is a co-author and panel member of the clinical practice guidelines for the VA regarding the use of hepatitis C drugs. She served as a clinical expert for the California Technology Assessment Forum (CTAF) meetings on hepatitis C drugs in 2014 and is currently a CTAF voting panel member and Vice Chair. She serves on the faculty of the UCSF Hepatitis C ECHO clinic, providing telemedicine consultation on hepatitis C management for providers in underserved and rural areas. As a researcher, she studies hepatitis C epidemiology and clinical outcomes, including long term outcomes of hepatocellular carcinoma and cirrhosis in large multicenter studies. Dr. Fox trains UCSF medical students and Internal Medicine residents. She sees patients in two settings – she has a large panel of primary care patients at the UCSF General Medicine practice, and she treats hepatitis C patients at the Liver Clinic at UCSF.

    Collapse ORNG Applications 
    Collapse Websites
    Collapse In The News

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
    List All   |   Timeline
    1. Fox RK, Taddei TH, Kaplan DE. Aspirin Use and Risk of Hepatocellular Carcinoma in Hepatitis B. JAMA Intern Med. 2019 Mar 18. PMID: 30882884.
      View in: PubMed
    2. Kaplan DE, Chapko MK, Mehta R, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Pocha C, Valderrama A, Taddei TH. Healthcare Costs Related to Treatment of Hepatocellular Carcinoma Among Veterans With Cirrhosis in the United States. Clin Gastroenterol Hepatol. 2018 Jan; 16(1):106-114.e5. PMID: 28756056.
      View in: PubMed
    3. Serper M, Taddei TH, Mehta R, D'Addeo K, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Goldberg DS, Valderrama A, Kaplan DE. Association of Provider Specialty and Multidisciplinary Care With Hepatocellular Carcinoma Treatment and Mortality. Gastroenterology. 2017 06; 152(8):1954-1964. PMID: 28283421.
      View in: PubMed
    4. Fox R. Going Viral: Why Eliminating the Burden of Hepatitis C Requires Enhanced Cooperation Between Specialists and Primary Care Providers. Dig Dis Sci. 2016 12; 61(12):3381-3383. PMID: 27619392.
      View in: PubMed
    5. Goldberg DS, Taddei TH, Serper M, Mehta R, Dieperink E, Aytaman A, Baytarian M, Fox R, Hunt K, Pedrosa M, Pocha C, Valderrama A, Kaplan DE. Identifying barriers to hepatocellular carcinoma surveillance in a national sample of patients with cirrhosis. Hepatology. 2017 03; 65(3):864-874. PMID: 27531119.
      View in: PubMed
    6. Kaplan DE, Dai F, Skanderson M, Aytaman A, Baytarian M, D'Addeo K, Fox R, Hunt K, Knott A, Mehta R, Pedrosa M, Pocha C, Valderrama A, Taddei T. Recalibrating the Child-Turcotte-Pugh Score to Improve Prediction of Transplant-Free Survival in Patients with Cirrhosis. Dig Dis Sci. 2016 11; 61(11):3309-3320. PMID: 27405990.
      View in: PubMed
    7. Fox RK, Muniraj T. Pharmacologic Therapies in Gastrointestinal Diseases. Med Clin North Am. 2016 Jul; 100(4):827-50. PMID: 27235617.
      View in: PubMed
    8. Chahal HS, Marseille EA, Tice JA, Pearson SD, Ollendorf DA, Fox RK, Kahn JG. Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population. JAMA Intern Med. 2016 Jan; 176(1):65-73. PMID: 26595724.
      View in: PubMed
    9. Kaplan DE, Dai F, Aytaman A, Baytarian M, Fox R, Hunt K, Knott A, Pedrosa M, Pocha C, Mehta R, Duggal M, Skanderson M, Valderrama A, Taddei TH. Development and Performance of an Algorithm to Estimate the Child-Turcotte-Pugh Score From a National Electronic Healthcare Database. Clin Gastroenterol Hepatol. 2015 Dec; 13(13):2333-41.e1-6. PMID: 26188137; PMCID: PMC4655141 [Available on 12/01/16].
    10. Fox RK. Toward the Effective Co-management of Patients with Cirrhosis by Primary Care Providers and Specialists. Dig Dis Sci. 2015 Sep; 60(9):2576-8. PMID: 25986522.
      View in: PubMed
    11. Belperio PS, Fox RK, Backus LI. The State of Hepatitis C Care in the VA. Fed Pract. 2015 Feb; 32(Suppl 2):20S-24S. PMID: 30766108.
      View in: PubMed
    12. Shah AD, Fox RK, Rushakoff RJ. Falsely Decreased HbA1c in a Type 2 Diabetic Patient Treated with Dapsone. Endocr Pract. 2014 Nov; 20(11):e229-32. PMID: 25100400; PMCID: PMC4423899.
    13. Fox RK. When to consider liver transplant during the management of chronic liver disease. Med Clin North Am. 2014 Jan; 98(1):153-68. PMID: 24266919.
      View in: PubMed
    14. Fox RK. Hepatitis B--more treatments, more testing, not enough data. J Gen Intern Med. 2011 Mar; 26(3):232-3. PMID: 21267669; PMCID: PMC3043180.
    15. Bräu N, Fox RK, Xiao P, Marks K, Naqvi Z, Taylor LE, Trikha A, Sherman M, Sulkowski MS, Dieterich DT, Rigsby MO, Wright TL, Hernandez MD, Jain MK, Khatri GK, Sterling RK, Bonacini M, Martyn CA, Aytaman A, Llovet JM, Brown ST, Bini EJ. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study. J Hepatol. 2007 Oct; 47(4):527-37. PMID: 17692986.
      View in: PubMed
    16. Fox RK, Currie SL, Evans J, Wright TL, Tobler L, Phelps B, Busch MP, Page-Shafer KA. Hepatitis C virus infection among prisoners in the California state correctional system. Clin Infect Dis. 2005 Jul 15; 41(2):177-86. PMID: 15983913.
      View in: PubMed
    17. Seligman HK, Fox RK. Treatment of acute hepatitis C with interferon alfa-2b. N Engl J Med. 2002 Apr 04; 346(14):1091-2. PMID: 11936120.
      View in: PubMed